The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bosio, C. M.
Right arrow Articles by Belisle, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosio, C. M.
Right arrow Articles by Belisle, J. T.
The Journal of Immunology, 2007, 178: 4538-4547.
Copyright © 2007 by The American Association of Immunologists, Inc.

Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu41

Catharine M. Bosio2, Helle Bielefeldt-Ohmann and John T. Belisle

Department of Microbiology, Immunology and Pathology, Colorado State University, Ft. Collins, CO 80523

Francisella tularensis is an obligate, intracellular bacterium that causes acute, lethal disease following inhalation. As an intracellular pathogen F. tularensis must invade cells, replicate, and disseminate while evading host immune responses. The mechanisms by which virulent type A strains of Francisella tularensis accomplish this evasion are not understood. Francisella tularensis has been shown to target multiple cell types in the lung following aerosol infection, including dendritic cells (DC) and macrophages. We demonstrate here that one mechanism used by a virulent type A strain of F. tularensis (Schu4) to evade early detection is by the induction of overwhelming immunosuppression at the site of infection, the lung. Following infection and replication in multiple pulmonary cell types, Schu4 failed to induce the production of proinflammatory cytokines or increase the expression of MHCII or CD86 on the surface of resident DC within the first few days of disease. However, Schu4 did induce early and transient production of TGF-beta, a potent immunosuppressive cytokine. The absence of DC activation following infection could not be attributed to the apoptosis of pulmonary cells, because there were minimal differences in either annexin or cleaved caspase-3 staining in infected mice compared with that in uninfected controls. Rather, we demonstrate that Schu4 actively suppressed in vivo responses to secondary stimuli (LPS), e.g., failure to recruit granulocytes/monocytes and stimulate resident DC. Thus, unlike attenuated strains of F. tularensis, Schu4 induced broad immunosuppression within the first few days after aerosol infection. This difference may explain the increased virulence of type A strains compared with their more attenuated counterparts.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a grant form the Colorado State University College Research Council and by Rocky Mountain Regional Center of Excellence National Institutes of Health Grant U01 AI056487-01.

2 Address correspondence and reprint requests to Dr. Catharine M. Bosio at the current address: National Institutes of Health/National Institute of Allergy and Infectious Diseases/Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT 59840. E-mail address: bosioc{at}niaid.nih.gov

3 Abbreviations used in this paper: LVS, live vaccine strain; BAL, bronchoalveolar lavage; BHI, brain-heart infusion; DC, dendritic cell; IHC, immunohistochemistry; MHCII, MHC class II; MLN, mediastinal lymph node.




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
K. England, C. am Ende, H. Lu, T. J. Sullivan, N. L. Marlenee, R. A. Bowen, S. E. Knudson, D. L. Knudson, P. J. Tonge, and R. A. Slayden
Substituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemia
J. Antimicrob. Chemother., November 1, 2009; 64(5): 1052 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. R. Wickstrum, S. M. Bokhari, J. L. Fischer, D. M. Pinson, H.-W. Yeh, R. T. Horvat, and M. J. Parmely
Francisella tularensis Induces Extensive Caspase-3 Activation and Apoptotic Cell Death in the Tissues of Infected Mice
Infect. Immun., November 1, 2009; 77(11): 4827 - 4836.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Sharma, Q. Li, B. B. Mishra, M. J. Georges, and J. M. Teale
Vaccination with an Attenuated Strain of Francisella novicida Prevents T-Cell Depletion and Protects Mice Infected with the Wild-Type Strain from Severe Sepsis
Infect. Immun., October 1, 2009; 77(10): 4314 - 4326.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Crane, S. L. Warner, and C. M. Bosio
A Novel Role for Plasmin-Mediated Degradation of Opsonizing Antibody in the Evasion of Host Immunity by Virulent, but Not Attenuated, Francisella tularensis
J. Immunol., October 1, 2009; 183(7): 4593 - 4600.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. C. Cowley
Editorial: Proinflammatory cytokines in pneumonic tularemia: too much too late?
J. Leukoc. Biol., September 1, 2009; 86(3): 469 - 470.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Sharma, Q. Li, B. B. Mishra, C. Pena, and J. M. Teale
Lethal pulmonary infection with Francisella novicida is associated with severe sepsis
J. Leukoc. Biol., September 1, 2009; 86(3): 491 - 504.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
H. J. Ray, Y. Cong, A. K. Murthy, D. M. Selby, K. E. Klose, J. R. Barker, M. N. Guentzel, and B. P. Arulanandam
Oral Live Vaccine Strain-Induced Protective Immunity against Pulmonary Francisella tularensis Challenge Is Mediated by CD4+ T Cells and Antibodies, Including Immunoglobulin A
Clin. Vaccine Immunol., April 1, 2009; 16(4): 444 - 452.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. N. Vojtech, G. E. Sanders, C. Conway, V. Ostland, and J. D. Hansen
Host Immune Response and Acute Disease in a Zebrafish Model of Francisella Pathogenesis
Infect. Immun., February 1, 2009; 77(2): 914 - 925.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. C. Chase, J. Celli, and C. M. Bosio
Direct and Indirect Impairment of Human Dendritic Cell Function by Virulent Francisella tularensis Schu S4
Infect. Immun., January 1, 2009; 77(1): 180 - 195.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. D. Hall, M. D. Woolard, B. M. Gunn, R. R. Craven, S. Taft-Benz, J. A. Frelinger, and T. H. Kawula
Infected-Host-Cell Repertoire and Cellular Response in the Lung following Inhalation of Francisella tularensis Schu S4, LVS, or U112
Infect. Immun., December 1, 2008; 76(12): 5843 - 5852.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. F. Huntley, P. G. Conley, D. A. Rasko, K. E. Hagman, M. A. Apicella, and M. V. Norgard
Native Outer Membrane Proteins Protect Mice against Pulmonary Challenge with Virulent Type A Francisella tularensis
Infect. Immun., August 1, 2008; 76(8): 3664 - 3671.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
T. Guina, D. Radulovic, A. J. Bahrami, D. L. Bolton, L. Rohmer, K. A. Jones-Isaac, J. Chen, L. A. Gallagher, B. Gallis, S. Ryu, et al.
MglA Regulates Francisella tularensis subsp. novicida (Francisella novicida) Response to Starvation and Oxidative Stress
J. Bacteriol., September 15, 2007; 189(18): 6580 - 6586.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Kirimanjeswara, J. M. Golden, C. S. Bakshi, and D. W. Metzger
Prophylactic and Therapeutic Use of Antibodies for Protection against Respiratory Infection with Francisella tularensis
J. Immunol., July 1, 2007; 179(1): 532 - 539.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.